Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC
Clinical trial NCT07365592 · RECRUITING
Trial details
- NCT number
- NCT07365592
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-09
- Primary completion
- 2029-12-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.